Physician profile
Brent E Stevenson
NPI 1649204926
$9,299.24
in general payments reported to CMS, 2019-2025
17 companies · $3,860 in 2025
The $3,860 reported for 2025 was more than what 86% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $571 · 2021: $890 · 2022: $723 · 2023: $1,269 · 2024: $1,527 · 2025: $3,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,506 · Honoraria: $2,925 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,506.45 |
| Honoraria | $2,925.00 |
| Education | $224.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $3,359.28 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $2,979.67 | 2019-2024 | |
| Harmony Biosciences LLC | $1,071.53 | 2020-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $530.83 | 2024-2025 | Lumryz |
| Inspire Medical Systems, INC. | $304.97 | 2023-2025 | Inspire |
| Zoll Respicardia, INC. | $235.22 | 2024-2025 | Remede System |
| Merck Sharp & Dohme LLC | $155.62 | 2020-2023 | Belsomra |
| Idorsia Pharmaceuticals US INC | $142.84 | 2022-2025 | Quviviq, Quviviq |
| Fisher & Paykel Healthcare INC | $127.06 | 2024-2025 | Fisher & Paykel Healthcare |
| Itamar Medical INC | $124.14 | 2024 | Watchpatone |
| Arbor Pharmaceuticals, INC. | $88.37 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $78.43 | 2024-2025 | Horizant |
| 3b Medical, INC. | $30.34 | 2023 | Luna |
| Philips North America LLC | $27.84 | 2025 | Home Pi Undivided |
| Lilly USA, LLC | $16.45 | 2024 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apria Healthcare LLC | $13.87 | 2021 | |
| Currax Pharmaceuticals LLC | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Stevenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.